Latest Breaking News On - எங்களுக்கு அலுவலகம் க்கு சிவில் உரிமைகள் - Page 2 : comparemela.com
SCOTT HEINS/OFFICE OF GOVERNOR ANDREW CUOMO
Advocacy group Disability Rights Connecticut says Governor Lamont’s new COVID vaccine policy that took effect on April 1 is unlawful and discriminatory and places people at increased risk.
Those 16 and older are now eligible to get vaccinated.
Deborah Dorfman is the executive director of Disability Rights Connecticut and said the Governor’s new policy seems image driven.
“It’s hard to believe it s not for a political purpose as well, which is to say oh look how fast we got a certain number of people vaccinated. The problem is that it hasn’t been and continues to be inequitable. It continues to put people who are at the highest risk at risk,” Dorfman said.
Connecticut
United-states
Deborah-dorfman
Us-office-for-civil-rights
Disability-rights-connecticut
Governor-lamont
Rights-connecticut
Brian-scott-smith
Covid-19
Covid-19-vaccine
Corona-virus
Nearly three quarters of eligible CT residents expected to be vaccinated by end of April
Officials are not tracking how many people receive accelerated access to vaccine
Beth Wright, kindergarten teacher in New Haven, gets vaccinated at Wilbur Cross High School.
State officials expect nearly three quarters of Connecticut residents 16 and older to have received a first dose of the COVID-19 vaccine by the end of this month.
Eligibility opened Thursday to all people regardless of age. Since Thursday, 50,000 residents ages 16 to 44 – the newest group granted access – received a first dose of the vaccine.
“We’re going to be getting some very high numbers of the percentage of the total Connecticut population vaccinated by the end of the month,” said Josh Geballe, the state’s chief operating officer. “We should be at about 60% of people having received their first dose. Keep in mind, that still includes a significant portion of the population younger than 16, who are
Connecticut
United-states
New-haven
Wilbur-cross-high-school
Beth-wright
Ned-lamont
Scott-gottlieb
Yehyun-kim
Josh-geballe
Centers-for-disease
Department-of-developmental-services
Pfizer